SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ: PDII), a pioneer in providing contract sales and commercialization services to the biopharmaceutical industry, today reported financial results for the three and 12 months ended December 31, 2008, and provided a business update. Highlights of the quarter and recent weeks include:
